Kenneth C. Griffin Esophageal Center of Northwestern Medicine, Department of Medicine, Division of Gastroenterology and Hepatology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.
Kenneth C. Griffin Esophageal Center of Northwestern Medicine, Department of Medicine, Division of Gastroenterology and Hepatology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA; Department of Gastroenterology, Hospital Clínic de Barcelona, Barcelona, Spain.
Gastrointest Endosc. 2024 Apr;99(4):499-510.e1. doi: 10.1016/j.gie.2023.10.048. Epub 2023 Oct 27.
BACKGROUND AND AIMS: The evaluation provided by functional lumen imaging probe (FLIP) panometry includes esophageal distensibility/compliance (mechanics) of the esophageal body and esophagogastric junction (EGJ) and esophageal motility (secondary peristalsis). We developed a composite score using these parameters to characterize physiomechanical function in patients with eosinophilic esophagitis (EoE). METHODS: Two hundred fifteen adult patients with EoE who completed FLIP panometry during sedated endoscopy with esophageal biopsy sampling were included. FLIP metrics of esophageal body Compliance, Contractile response, Distensibility plateau, and maximum EGJ Diameter (C2D2) were scored as 0 for normal versus 1 or 2 for increasing degree of abnormality. Scores were summed to calculate the composite C2D2 score. RESULTS: The C2D2 score had a significant positive correlation with mucosal eosinophil count (ρ = .241) and total Endoscopic EoE Reference Score (ρ = .467). Among 46 patients off treatment at the baseline evaluation, future proton pump inhibitor (PPI) responders (ie, achieved mucosal eosinophil count <15 per high-powered field after PPI treatment) had lower C2D2 scores than PPI nonresponders (median, 2 [interquartile range, 1-3] vs 4 [interquartile range, 2-6], respectively; P = .003). A regression model (that controlled for age, sex, and baseline eosinophil count) showed a C2D2 score ≤3 had an odds ratio of 14.5 (95% confidence interval, 2.6-85) to predict future PPI response. However, total Endoscopic EoE Reference Scores (P = .142) and baseline eosinophil count (P = .480) did not differ between PPI responders and PPI nonresponders. CONCLUSIONS: This composite score of FLIP panometry metrics, the C2D2 score, may facilitate characterizing physiomechanical function in EoE and serve as an objective outcome measure.
背景与目的:功能腔内成像探头(FLIP)测压计的评估包括食管体的可扩张性/顺应性(力学)和食管胃连接部(EGJ)以及食管动力(继发性蠕动)。我们开发了一种使用这些参数的综合评分来描述嗜酸性食管炎(EoE)患者的生理力学功能。
方法:纳入了 215 名在镇静内镜下接受食管活检采样时完成 FLIP 测压计检查的成人 EoE 患者。FLIP 指标,包括食管体顺应性、收缩反应、扩张平台和最大 EGJ 直径(C2D2),正常评分 0,异常程度增加评分 1 或 2。评分相加计算复合 C2D2 评分。
结果:C2D2 评分与黏膜嗜酸性粒细胞计数(ρ=0.241)和总内镜 EoE 参考评分(ρ=0.467)呈显著正相关。在基线评估时停用治疗的 46 名患者中,未来质子泵抑制剂(PPI)应答者(即,PPI 治疗后黏膜嗜酸性粒细胞计数<15 个/高倍视野)的 C2D2 评分低于 PPI 无应答者(中位数分别为 2 [四分位距 1-3]和 4 [四分位距 2-6];P=0.003)。回归模型(控制年龄、性别和基线嗜酸性粒细胞计数)显示,C2D2 评分≤3 的比值比为 14.5(95%置信区间 2.6-85),可预测未来 PPI 反应。然而,PPI 应答者和 PPI 无应答者之间的总内镜 EoE 参考评分(P=0.142)和基线嗜酸性粒细胞计数(P=0.480)没有差异。
结论:FLIP 测压计指标的这种复合评分,即 C2D2 评分,可能有助于描述 EoE 的生理力学功能,并作为客观的结局测量指标。
Gastroenterology. 2023-9
J Clin Gastroenterol. 2024-3-1
Clin Gastroenterol Hepatol. 2024-3
Clin Gastroenterol Hepatol. 2022-8
Clin Gastroenterol Hepatol. 2013-4-13
Aliment Pharmacol Ther. 2025-8
Gastroenterol Hepatol (N Y). 2024-10
Clin Endosc. 2025-1
Curr Allergy Asthma Rep. 2024-5
Gastroenterology. 2023-9
Clin Gastroenterol Hepatol. 2024-3
Neurogastroenterol Motil. 2023-4
N Engl J Med. 2022-12-22
Clin Gastroenterol Hepatol. 2022-8
Am J Gastroenterol. 2021-12-1
Clin Gastroenterol Hepatol. 2022-6
Gastroenterology. 2021-10
Neurogastroenterol Motil. 2022-1